1. Home
  2. HRB vs NAMS Comparison

HRB vs NAMS Comparison

Compare HRB & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$40.38

Market Cap

4.9B

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$32.27

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
NAMS
Founded
1955
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.1B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
HRB
NAMS
Price
$40.38
$32.27
Analyst Decision
Sell
Strong Buy
Analyst Count
2
8
Target Price
$41.00
$46.75
AVG Volume (30 Days)
1.8M
977.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
5.34%
N/A
EPS Growth
6.55
N/A
EPS
3.38
N/A
Revenue
$3,159,931,000.00
N/A
Revenue This Year
$4.39
$17.96
Revenue Next Year
$3.21
$540.65
P/E Ratio
$12.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.16
$21.14
52 Week High
$56.76
$42.21

Technical Indicators

Market Signals
Indicator
HRB
NAMS
Relative Strength Index (RSI) 57.49 46.76
Support Level $29.24 $29.23
Resistance Level $44.86 $37.29
Average True Range (ATR) 1.15 2.05
MACD 0.15 -0.44
Stochastic Oscillator 53.70 31.22

Price Performance

Historical Comparison
HRB
NAMS

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: